We found that ELAVL1 was significantly overexpressed in 18 tumors (Kolgomorov-Smirnov FDR < 0.05) (Fig. 1a and Supplementary Data 1), including breast cancer (BRCA), compared to normal controls; this difference was sustained in 16 tumors, including breast cancer (among others), when a paired normal: tumor comparison was made (Supplementary Fig. 1a and Supplementary Data 1). Here, ELAVL1 is linked to breast carcinoma.